Lexeo Therapeutics, Inc.

XNAS

Last traded price · USD

$3.03

−6.19%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 19:13 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $3.23
Volume: 654
Day's high: —
Day's low: —

In brief

Lexeo Therapeutics, Inc. is a US-listed company listed on Nasdaq, valued at about $249M.
Its shares closed at $3.23 on 4 Nov 2026, down 61.3% over the past year.
From India you can buy LXEO in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Lexeo Therapeutics, Inc. (LXEO) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole LXEO share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade LXEO options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: −2.1% (SPY −1.6%). 3 months: −27.4% (SPY −0.4%). 1 year: −61.3% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: LXEO, SPY · as of 4 Nov 2026
10.0 days to cover short interest
17.6M shares were sold short at the 15 Oct 2026 settlement, 21.4% of the 82.0M shares outstanding; covering them would take 10.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
26.7% above its 52-week low
Closed at $3.23 on 4 Nov 2026: 70.6% below the 52-week high of $10.99 (23 Dec 2025) and 26.7% above the low of $2.55 (19 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $3.23 was 11.3% below its 50-day average ($3.64) and 37.3% below its 200-day average ($5.15). It has closed below the 200-day for 165 sessions, since 12 Mar 2026. The 50-day average crossed below the 200-day on 26 Mar 2026, 154 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−2.1%

6 months−48.2%

1 year−61.3%

5 years—

Newswire

About

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Website

Notable moves

October 7, 2025
+28.90%
April 9, 2025
+29.67%
March 24, 2025
+50.92%

Lexeo Therapeutics, Inc.

XNAS

Last traded price · USD

$3.03

−6.19%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 19:13 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $3.23
Volume: 654
Day's high: —
Day's low: —

In brief

Lexeo Therapeutics, Inc. is a US-listed company listed on Nasdaq, valued at about $249M.
Its shares closed at $3.23 on 4 Nov 2026, down 61.3% over the past year.
From India you can buy LXEO in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Lexeo Therapeutics, Inc. (LXEO) shares from India?

Do I need the price of a whole LXEO share to invest?

How much can I invest in US stocks in a year?

Can I trade LXEO options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY over 1 year
1 month: −2.1% (SPY −1.6%). 3 months: −27.4% (SPY −0.4%). 1 year: −61.3% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: LXEO, SPY · as of 4 Nov 2026
10.0 days to cover short interest
17.6M shares were sold short at the 15 Oct 2026 settlement, 21.4% of the 82.0M shares outstanding; covering them would take 10.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
26.7% above its 52-week low
Closed at $3.23 on 4 Nov 2026: 70.6% below the 52-week high of $10.99 (23 Dec 2025) and 26.7% above the low of $2.55 (19 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $3.23 was 11.3% below its 50-day average ($3.64) and 37.3% below its 200-day average ($5.15). It has closed below the 200-day for 165 sessions, since 12 Mar 2026. The 50-day average crossed below the 200-day on 26 Mar 2026, 154 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−2.1%

6 months−48.2%

1 year−61.3%

5 years—

Newswire

About

Website

Notable moves

October 7, 2025
+28.90%
April 9, 2025
+29.67%
March 24, 2025
+50.92%

Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc. in brief

Behind SPY over 1 year

10.0 days to cover short interest

26.7% above its 52-week low

Below its 50- and 200-day averages

Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc. in brief

Behind SPY over 1 year

10.0 days to cover short interest

26.7% above its 52-week low

Below its 50- and 200-day averages